DEA announces release of 2018 Pennsylvania Drug-Related Overdose Death Report
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • DEA announces release of 2018 Pennsylvania Drug-Related Overdose Death Report

DEA announces release of 2018 Pennsylvania Drug-Related Overdose Death Report

October 03, 2019
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Media Requests
Phone Number: (215) 861-3474

​​

PHILADELPHIA – Special Agent in Charge of the Drug Enforcement Administration’s Philadelphia Field Division Jonathan A. Wilson today announced today the release of the Drug-Related Overdose Deaths in Pennsylvania, 2018 report.

 

For the third year in a row, the DEA Philadelphia Field Division has partnered with the University of Pittsburgh School of Pharmacy’s Program Evaluation Research Unit, Pennsylvania Opioid Overdose Reduction Technical Assistance Center to produce this report.

 

Key findings from the report include:

  • In 2018, approximately 4,491 drug-related overdose deaths were reported by Pennsylvania coroners and medical examiners—an 18% decrease from 2017. In 2018, 12 people in Pennsylvania died of a drug-related overdose each day.
     
  • The drug-related overdose death rate in Pennsylvania was 35 per 100,000 people in 2018. The overdose rate decreased in 41 counties, increased in 23, and remained unchanged in 3. The ten highest overdose death rates were concentrated in eastern and central Pennsylvania counties in 2018, compared to southwestern Pennsylvania counties in 2017.
     
  • Despite a statewide decrease in overdose deaths, the rate of decrease by region was not uniform. The largest decrease in overdose death rates occurred in the Southwest District2 (41%), while rates of decrease in the remaining districts ranged from 11% to 1%.
     
  • The presence of an opioid, illicit or prescription, was reported in 82% of drug-related overdose deaths in Pennsylvania in 2018, compared to 84% of drug-related overdose deaths in 2017.
     
  • Fentanyl was the most frequently identified substance in drug-related overdose deaths (70% of deaths), remaining consistent with 2017. The younger population demographic was associated with fentanyl usage, as fentanyl was present in more than 75% of drug-related overdose decedents within the 15 to 24 and 25 to 34 age groups.
     
  • Heroin remained the second most frequently identified substance in drug-related overdose deaths (35%), followed by cocaine (33%), benzodiazepines (28%), and fentanyl-related substances (FRSs) (23%).
     
    The Drug-Related Overdose Deaths in Pennsylvania, 2018 report is available to the public for download at www.dea.gov or www.OverdoseFreePA.org. 

     
    Questions regarding the report may be addressed to Supervisory Special Agent Patrick J. Trainor, Public Information Officer, at either (571) 362-5391 or patrick.j.trainor@usdoj.gov.
     
    #   #   #
     

 

 

Download Press Release
###
Fentanyl Heroin
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Thomas Hodnett Special Agent in Charge - Philadelphia
@DEAPhiladelphia
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster